Solidpharma
Timeline
31 events since 2010The 2026 accounts are due by 31-12-2026.
Legal-form changeGeneral meeting of 29-12-20223 points ▸
- General meeting of 29-12-2022
- Article 29 of the articles of association amended
- The capital is divided into 6,400 shares
- The deed holds 5 more points.
Registered office moved from Affligem to GhentThe registered office moved from Krokussenlaan 20, 1790 Affligem to Heistraat 16, 9052 Gent · (director) and (director) resign · appointed as director · General meeting of 14-07-20209 points ▸
- General meeting of 14-07-2020
- resigns as director
- resigns as director
- appointed as director
- acts as permanent representative
- Discharge granted to
- Discharge granted to
- Board meeting of 14-07-2020
- The registered office moved to Heistraat 16, 9052 Gent
Company renamed to SOLIDPHARMACapital decrease of €45,400 to €18,600 · The capital fell from €64,000 to €18,600 · General meeting of 20-12-20174 points ▸
- General meeting of 20-12-2017
- Name change, SOLIDPHARMA
- The capital was reduced by €45,400
- The capital is €18,600
- The deed holds 1 more point.
Merger: SOLIDPHARMA takes over VOF EM ConsultingCapital increase of €1,000 to €64,000 · The capital rose from €63,000 to €64,000, with 100 new shares · changes role from director to manager · General meeting of 30-05-201312 points ▸
- General meeting of 30-05-2013
- The operation takes effect in the accounts on 01-01-2013
- The capital is €64,000
- The capital was increased by €1,000
- The capital is €64,000, divided into 6,400 shares
- Legal-form conversion, from public limited company to private limited company (pre-2019)
- VOF EM Consulting resigns as director
- Discharge granted to VOF EM Consulting
- resigns as director
- Discharge granted to
- appointed as manager
- appointed as manager
- The deed holds 13 more points.
Merger proposal: Solidpharma N.V. takes over EM Consulting2 points ▸
- Merger by absorption
- The operation takes effect in the accounts on 01-01-2013
- The deed holds 4 more points.
Registered office moved from Rumst to AffligemThe registered office moved from Donkerstraat 9, 2840 Rumst to Krokussenlaan 20, 1790 Affligem · resigns as director · acts as permanent representative · General meeting of 29-08-20115 points ▸
- General meeting of 29-08-2011
- resigns as director
- acts as permanent representative
- appointed as director
- The registered office moved to Krokussenlaan 20, 1790 Affligem
1 director resigning · , and act as permanent representatives · General meeting of 14-12-20106 points ▸
- General meeting of 14-12-2010
- resigns as director
- acts as permanent representative
- Board meeting of 14-12-2010
- acts as permanent representative
- acts as permanent representative
- The deed holds 1 more point.
2 directors appointed, 2 resignations and resign · and appointed · and act as permanent representatives · General meeting of 15-11-20109 points ▸
- General meeting of 15-11-2010
- resigns as director
- Discharge granted to
- resigns as director
- Discharge granted to
- appointed as director
- acts as permanent representative
- appointed as director
- acts as permanent representative
IncorporationFounding capital of €63,000, 6,300 shares · Founded by , and · , and appointed · published on 07-06-20108 points ▸
- Founded by
- Founded by
- Founded by
- The founding capital is €63,000, divided into 6,300 shares
- appointed as director
- acts as permanent representative
- appointed as director
- appointed as director
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Solidpharma was incorporated on 19 May 2010 by and two private individuals, with a starting capital of €63,000.12 The registered office moved to Affligem in 2011 and to Ghent in 2020.34 In 2013 the capital was increased by €1,000 to €64,000. After a decrease in 2018 the capital stands at €18,600.5 EM Consulting was merged into the company in 2013.5 In 2018 the company took the name SOLIDPHARMA.6 Since 2020, has served as director.7 Total assets rose from €856,989 in 2018 to €2.3m in 2025 and headcount from 2.7 to 6 full-time equivalents.8